These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1296978)

  • 1. Characteristics of 1,3-bis-(2-ethoxycarbonylchromon-5-yloxy)-2-((S)- lysyloxy)propane dihydrochloride (N-556), a prodrug for the oral delivery of disodium cromoglycate, in absorption and excretion in rats and rabbits.
    Yoshimi A; Hashizume H; Kitagawa M; Nishimura K; Kakeya N
    J Pharmacobiodyn; 1992 Dec; 15(12):681-6. PubMed ID: 1296978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption mechanism of 1,3-bis(2-ethoxycarbonylchromon-5-yloxy)-2-((S)-lysyloxy )propane dihydrochloride (N-556), a prodrug for the oral delivery of disodium cromoglycate.
    Yoshimi A; Hashizume H; Kitagawa M; Nishimura K; Kakeya N
    Biol Pharm Bull; 1993 Apr; 16(4):375-8. PubMed ID: 8358388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of hydrolysis of amino acid moiety in water-soluble prodrugs of disodium cromoglycate for increased oral bioavailability.
    Yoshimi A; Hashizume H; Tamaki S; Tsuda H; Fukata F; Nishimura K; Yata N
    J Pharmacobiodyn; 1992 Jul; 15(7):339-45. PubMed ID: 1447681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of N-556 on experimental allergy models in rats.
    Nakamura S; Yamamura H; Kohno S; Ohata K; Yoshimi A; Nishimura K; Kakeya N
    Arerugi; 1990 Dec; 39(12):1621-8. PubMed ID: 2096808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion.
    Aswania OA; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 1999 Jun; 47(6):613-8. PubMed ID: 10383538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of topical disodium cromoglycate and its preservatives by soft contact lenses.
    Iwasaki W; Kosaka Y; Momose T; Yasuda T
    CLAO J; 1988; 14(3):155-8. PubMed ID: 3145159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of the amount of drug deposited in the lungs of asthmatic children using disodium cromoglycate as the marker].
    Iwasaki E; Yamaura M; Baba M
    Arerugi; 1993 Aug; 42(8):907-13. PubMed ID: 8250730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absorption, metabolism and excretion of disodium cromoglycate in nine animal species.
    Ashton MJ; Clark B; Jones KM; Moss GF; Neale MG; Ritchie JT
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):319-28. PubMed ID: 4203381
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.
    Bangphumi K; Kittiviriyakul C; Towiwat P; Rojsitthisak P; Khemawoot P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):777-785. PubMed ID: 26563392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
    Lal J; Gupta RC
    Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absorption, excretion and metabolism of disodium (14C)cromoglycate in man.
    Walker SR; Richards AJ; Paterson JW
    Biochem J; 1971 Nov; 125(2):27P. PubMed ID: 5004195
    [No Abstract]   [Full Text] [Related]  

  • 18. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate.
    Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL
    Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and urinary excretion of disodium cromoglycate afer inhalation by human volunteers.
    Moss GF; Jones KM; Ritchie JT; Cox JS
    Toxicol Appl Pharmacol; 1971 Oct; 20(2):147-56. PubMed ID: 5002434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.